|
|
- 2019
Mitohormesis Primes Tumor Invasion and MetastasisDOI: https://doi.org/10.1016/j.celrep.2019.04.095 Abstract: ？ Evidence of endogenous mitohormesis in breast cancer cell lines and primary tumors ？ Mitohormetic priming of tumor cells leads to increased basal activation of the UPRmt ？ Mitohormesis and UPRmt activation makes cancer cells more invasive and metastatic ？ UPRmt enriched breast cancer patients have worse clinical outcome
|
